Statistics for Biosyent Inc (id:1299 RX)

Valuation metrics

Market cap

129.20M

Enterprise value

111.18M

Trailing P/E (ttm)

18.58

Forward P/E

19.91

PEG ratio

19.91

Price/Sales (ttm)

3.82

Price/Book (mrq)

3.65

Enterprise Value/Revenue

3.29

Enterprise Value/EBITDA

12.97

Overview

Shares outstanding

11.59M

Float

8.98M

Shares short

357.00

% Held by insiders

0.34%

% Held by institutions

0.01%

Average volume (10 days)

1.87K

Average volume (90 days)

Price summary

52-Week low

8.24

52-Week high

11.49

52-Week change

24.73%

Beta

0.92

50-Day moving average

10.97

200-Day moving average

9.64

Dividends and splits

Forward annual dividend rate

0.18

Forward annual dividend yield

0.02

Trailing annual dividend rate

0.17%

Trailing annual dividend yield

0.02

5-Year annual dividend yield

Payout ratio

0.28

Dividend date

September 15th, 2024

Ex-dividend date

September 04th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

21.14%

Operating margin

21.54%

Operational effectiveness

Return on assets

12.86%

Return on equity

20.88%

Income statement

Revenue (ttm)

2.88

Revenue per share (ttm)

2.88

Quarterly revenue growth (yoy)

0.06

Gross profit (ttm)

25.60M

EBITDA

10.00M

Net income to common (ttm)

7.15M

Diluted EPS (ttm)

0.60

Quarterly earnings growth (yoy)

6.50%

Balance sheet

Total cash (mrq)

17.41M

Total cash per share (mrq)

1.50

Total debt (mrq)

1.13M

Total Debt/Equity (mrq)

3.19

Current ratio (mrq)

613.20%

Book value per share (mrq)

3.06

Cash flow

Cash flow statement

2.53M

Levered free cash flow (LFCF)

1.75M